Discovery Laboratories, Inc. (NASDAQ:DSCO)

It's shameful that I actually own shares of this, it's like playing roullete and betting your money on double aught, losing and then redoubling your bet after the dillutive financing and past failures.

My cost basis is $3.63 per share (over three purchases) and I have an open order to sell 4/5 of my posisition starting at $3.20 (hopefully it gets back that high again prior to March 6th), I'm fine with the loss because I don't have that much invested in this stock. The rest of my shares: I'm putting my money on green one last time.

Surfaxin should be approved this time!Keep your fingers crossed Zz

speculatiooooon

Spec Play with March 6th PDUFA date. 4th times the charm? Or is it 5 now? 6?

Yes, I'm back. A full eighteen months after I started plugging this stock, the Imp might be finally coming out of its bottle. I gave up on my last green thumb right at the bottom and tried to get greedy with a new entry point. The stock outsmarted me yet again and has been running the last three weeks. I hate to miss a bottom but I'd kick myself even harder if the stock continued to run up ahead of the Surfaxin PDUFA on March 6, and God only knows what I might do if Surfaxin actually were to be approved and I didn't have it in CAPS.

Don't follow me on Discovery Labs. I'm seriously underwater on 6666 shares I bought before the surprise reverse split and dilutive financing.

Completely speculative.

After three FDA rejections on Surfaxin, I have little confidence that this company is even capable of bringing a product to market. The only thing they're discovering is how to squander shareholder value.

History always seems to repeats itself...

Riding out the storm till patent is approved or not.

Should go higher now that Porte has capitulated! Seems that small biotech has taken the interest of the big boys with recent increases in price and volume.

Likely going to zero before any Surfaxin approval.

Down we go!

FDA approval of its major drug Surfaxin will push share price to at least 10.

DSCO has comeout with a positive outlook during the last couple of weeks. The trend looks to be positive since they have currently completed batch 1 of trials and are waiting to complete the remaining 3 batches which will be sufficient enough to fulfill the needs of the FDA. The outlook looks promising enough with the financials too since they have a positive cash flow and are ready to submit to the FDA in early third quarter. With all this components which adds up to a successful progression towards the completion of FDA needs and requirements. My Target will be $10 to $12 before the early fouth quarter and then rise upto to $25 to $35 after the approval. ( which will still be about a $1.7 to $2 before the reverse split. )

Both ZZlangerhans and porte own significant quantities of this stock, and now I do as well. Adding to my position as the stock drops and hoping for approval by the FDA later in 2011.

see this post.
http://caps.fool.com/Blogs/dsco/539223.

Momentum21 haiku

Disco is not dead

The FDA has it wrong

Rise up from the ash

close to " yl" price this is a bargain price and undervalued.

This is a swing for the fences. Hope it goes up as they get closer to FDA decision. Do you hang on for the ride up or down after the decision comes? Only buy with money you can spare because this one could go either way.